ERα and ERβ have an approximate ratio of 1/2 in normal ovarian tissues, therefore, women who did not accept steroid-resembling estrogen treatment had a lower risk of having ovarian cancer (31). The gene discussed is ESR2; the disease is ovarian carcinoma.